Status:

RECRUITING

Description of the Copper Concentration in Breast Milk in Women Treated for Wilson's Disease

Lead Sponsor:

Fondation Ophtalmologique Adolphe de Rothschild

Conditions:

Wilson's Disease

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

Wilson's disease is a rare genetic disease, affecting less than 1,500 people in France. The transmission is autosomal recessive linked to an anomaly of the ATP7B gene on chromosome.This gene codes for...

Eligibility Criteria

Inclusion

  • Criteria for inclusion :
  • Patient aged 18 years or over.
  • Wilson's disease fulfilling the criteria for the Leipzig score
  • Pregnancy in progress whatever the term.
  • Express consent to participate in the study.
  • Affiliate or beneficiary of a social security system.
  • Criteria for non-inclusion :
  • Liver transplant patient
  • No affiliation to Social Security system
  • VuInability to give free and informed consent
  • Patient benefiting from a legal protection measure

Exclusion

    Key Trial Info

    Start Date :

    May 11 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    August 1 2026

    Estimated Enrollment :

    20 Patients enrolled

    Trial Details

    Trial ID

    NCT05183165

    Start Date

    May 11 2022

    End Date

    August 1 2026

    Last Update

    December 17 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Fondation Adolphe de Rothschild

    Paris, France, 75019